Glucose Lowering to Control Macrovascular Disease in Type 2 Diabetes Treating the Wrong Surrogate End Point?

被引：14
作者：
Goodarzi, Mark O. [5 ,6 ]
Psaty, Bruce M. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Washington, Cardiovasc Hlth Res Unit, Dept Med, Seattle, WA 98101 USA
[2] Univ Washington, Cardiovasc Hlth Res Unit, Dept Epidemiol, Seattle, WA 98101 USA
[3] Univ Washington, Cardiovasc Hlth Res Unit, Dept Hlth Serv, Seattle, WA 98101 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Inst Med Genet, Los Angeles, CA 90048 USA
[6] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 300卷 / 17期
关键词：
D O I：
10.1001/jama.2008.510
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2051 / 2053
页数：3
相关论文
共 15 条
  • [1] Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes
    Abraira, C
    Colwell, J
    Nuttall, F
    Sawin, CT
    Henderson, W
    Comstock, JP
    Emanuele, NV
    Levin, SR
    Pacold, I
    Lee, HS
    Silbert, CK
    Cxypoliski, R
    Vasquez, M
    Kernan, D
    Niewoehner, C
    Backes, M
    Bradley, M
    Bradley, M
    Crow, R
    Rubino, F
    Bushnell, D
    Pfeifer, M
    Service, FJ
    Howard, B
    Chew, E
    Hoogwerf, B
    Seigel, D
    Clark, CM
    Olefsky, JM
    Porte, D
    Sussman, KE
    Johnson, N
    Christine, B
    Tir, K
    Sather, M
    Day, P
    Morgan, N
    Deykin, D
    Gold, J
    Huang, P
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) : 181 - 188
  • [2] Dandona P, 2004, METAB SYNDR RELAT D, V2, P137, DOI 10.1089/met.2004.2.137
  • [3] Hyperinsulinemia as an independent risk factor for ischemic heart disease
    Despres, JP
    Lamarche, B
    Mauriege, P
    Cantin, B
    Dagenais, GR
    Moorjani, S
    Lupien, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) : 952 - 957
  • [4] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
    Dormandy, JA
    Charbonnel, B
    Eckland, DJA
    Erdmann, E
    Massi-Benedetti, M
    Kmoules, IK
    Skene, AM
    Tan, MH
    Lefébvre, PJ
    Murray, GD
    Standl, E
    Wilcox, RG
    Wlhelmsen, L
    Betteridge, J
    Birkeland, K
    Golay, A
    Heine, RJ
    Korányi, L
    Laakso, M
    Mokán, M
    Norkus, A
    Pirags, V
    Podar, T
    Scheen, A
    Scherbaum, W
    Schernthaner, G
    Schmitz, O
    Skrha, J
    Smith, U
    Taton, J
    [J]. LANCET, 2005, 366 (9493) : 1279 - 1289
  • [5] Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743
  • [6] Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells
    Goalstone, ML
    Natarajan, R
    Standley, PR
    Walsh, MF
    Leitner, JW
    Carel, K
    Scott, S
    Nadler, J
    Sowers, JR
    Draznin, B
    [J]. ENDOCRINOLOGY, 1998, 139 (10) : 4067 - 4072
  • [7] Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease - The San Antonio Heart Study
    Hanley, AJG
    Williams, K
    Stern, MP
    Haffner, SM
    [J]. DIABETES CARE, 2002, 25 (07) : 1177 - 1184
  • [8] HOLMAN RR, 10 YEAR FOLLOW UP IN
  • [9] The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort
    Kronmal, RA
    Barzilay, JI
    Tracy, RP
    Savage, PJ
    Orchard, TJ
    Burke, GL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2852 - 2858
  • [10] Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    Nathan, DM
    Cleary, PA
    Backlund, JYC
    Genuth, SM
    Lachin, JM
    Orchard, TJ
    Raskin, P
    Zinman, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2643 - 2653
12